Connect with us

Health

Researchers report on novel SARS-CoV-2 Israeli strain with unique spike glycoprotein – News-Medical.Net

Researchers from Israel describe a novel SARS-CoV-2 strain with a non-synonymous mutation in its spike glycoprotein, designated as P681H; nevertheless, its emergence…

Published

on

Article feature image

In a recent medRxiv* preprint report, a research group from Israel described a novel SARS-CoV-2 strain with a non-synonymous mutation in its spike glycoprotein, designated as P681H; nevertheless, its emergence has not been associated with increased infections rate, facilitated spread or vaccine evasion.
The coronavirus disease 2019 (COVID-19) is still running rampant all over the world. As of March 2021, Israel found itself amidst the third wave of the infection. This resulted in tightening the…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending